Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes
Status:
Completed
Trial end date:
2021-10-04
Target enrollment:
Participant gender:
Summary
Meconium stained amniotic fluid increases the risk of maternal complications (e.g., dystocia,
operative delivery, and postpartum endometritis) and neonatal complications (e.g., sepsis,
admission to the neonatal intensive care unit [NICU], and meconium aspiration syndrome). The
goal of the study is to compare between Azithromycin vs Placebo in cases of meconium stained
amniotic fluid during the first stage of labor in multigravida women and their effect on
maternal and neonatal outcomes.